Organovo Holdings, Inc. (ONVO)

[riaguy]

Sales increases are the only answer unless they can sell the company to one of the big pharmacy companies.
Keith Murphy may be a great scientist but so far, he's proven to be less than effective as a public company CEO. It appears that the signing of 10 of the 25 majors has done nothing for sales or the bottom line so, either the signings were complimentary fluff or the science is not as impressive as many of us thought.
For those of us with a cost basis above 5, it may be time to look elsewhere, hope for a management change, or wish for a buyout.